Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats
Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
Why the Healthcare Industry MUST Care About the Caregiver
Caregivers are vital in the treatment of a patient, whether at home or in a...
Ways Pharma Showed Patients How They Matter
Patient centricity is transforming the life sciences industry today. Here are outstanding examples of how...
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences
The growth and adoption of the internet and mobile technology have provided publishers and authors...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...